U.S. FDA vs. Wearables: The 2026 Regulatory Showdown for Digital Health

Medical Device Global Market Access · Mar 25, 2026 · 3m

This episode explores the evolving regulatory landscape for digital health, focusing on the U.S. FDA's projected stance in 2026. We dissect the critical line between general wellness wearables and regulated medical devices, analyzing how advanced features like blood pressure monitoring, sleep analysis, and AI coaching are forcing new regulatory clarity. We delve into the importance of a product's intended use, its marketing claims, and the level of risk it presents to the user as key factors in the FDA's classification process. - Where does the FDA draw the line between a wellness wearable…